Cytiva (formerly GE Life Sciences)

Bioprocessing Solutions for Development and Manufacture of Biotherapeutics and Vaccines

Bjorkgatan 30, SE-75184 Uppsala, Sweden



Cytiva, provides bioprocessing products and services to the biopharmaceutical industry for the development and manufacture of therapeutics and vaccines.

The company uses its scientific knowledge and technical expertise to help biomanufacturers increase speed-to-market, reduce costs, and improve productivity.

Single-use solutions for bioprocessing

The company provides a wide range of innovative single-use solutions designed to achieve high productivity. Ranging from single-use workflows and biomanufacturing facilities to disposable chromatography columns, the company’s offerings help drive collaboration in the pharmaceutical industry.

Upstream and downstream bioprocessing

Cytiva provides a wide range of integrated products and solutions to meet the needs of the biopharmaceutical industry for upstream and downstream bioprocessing.

Its portfolio includes products for cell culture and fermentation (HyClone™ cell culture media, sera, process liquids, ReadyToProcess WAVE™, Xcellerex™ bioreactors and Xcellerex fermentors), chromatography (ÄKTA™ chromatography system, chromatography columns and resins, and in-line conditioning systems), filtration (tangential flow filtration and ULTA™ normal flow filtration products), and liquid preparation and management (Xcellerex single-use mixers, ReadyKart™ mobile processing stations, ReadyToProcess™ storage bins and assemblies, and ReadyCircuit™ bag assemblies and ReadyMate™ connectors).

Cytiva also offers single-use systems, components, assemblies, and manufacturing facility solutions.

Biomanufacturing design and management for therapies and vaccines

Cytiva offers drug developers an array of biomanufacturing solutions that increase efficiency and optimize productivity. GE’s Enterprise Solutions provide an end-to-end platform for biologics management with innovative, modular solutions for the launch of new molecules, bringing biosimilars to an emerging market, or expanding biomanufacturing capacity to support production needs. Enterprise Solutions provides clients with new options to achieve their biomanufacturing goals.

FlexFactory™ is an integrated, single-use, or hybrid biomanufacturing platform that provides rapid access to current good manufacturing practice (cGMP) manufacturing capacity while providing flexibility.

The KuBio™ facilities and BioPark campus each offer a configurable design space to meet the client’s biomanufacturing needs. These turnkey facility solutions delay capital investment, reduce business risk, and improve speed-to-market.

Fast Trak biomanufacturing services

Cytiva provides a wide range of Fast Trak™ support services for drug development applications, including increasing existing capacity, launching a new molecule, and bringing biosimilars to market. The company helps manufacturers stay competitive and maintain high speed-to-market.

Performed with open collaboration and transparency, the company offers services to support cell culture medium development, upstream and downstream process development, clinical manufacturing, analytical development, quality control, and process transfer.

Cytiva’s Fast Trak portfolio supports quick development from molecule to market, ensuring market approval is reached in as short a time and as cost-effectively as possible. The company also accelerates outcomes, mitigates risks and conducts its processes with full transparency to meet its clients’ needs.

In addition, Cytiva offers education courses globally for practical, hands-on bioprocess training. Fast Trak courses are offered at nine locations worldwide, in addition to on-demand courses.

Bioprocess security of supply

Higher productivity, purity, and yield have been the driving forces when designing manufacturing processes for biopharmaceuticals.

The choices you make today will impact your manufacturing process for several years ahead.

For the development of an optimised process and for consistent and cost-effective biopharmaceutical production, a close collaboration between the manufacturer and its supplier is beneficial.

Cytiva offers products, services and support to assist you throughout your product’s lifecycle.

Enterprise Solutions

Changes in the bioprocessing market demand new ways of thinking. The industry needs smart solutions for easily scaling up or down production. Financial and production risks must also be minimized while adhering to strict demands from regulating bodies.

Single-use Solutions

Single-use manufacturing solutions cover technical, operational, economic and strategic considerations for single-use technology and implementation.

Fast Trak Services

Expertise lies in knowing what needs to be done and what does not need to be done. These factors are equally important for reducing time-to-market.

Upstream Bioprocessing

GE Healthcare knows that speed is important to you. That’s why it focuses on increasing productivity, optimizing protein quality and simplifying your operations right from the start.

Downstream Bioprocessing

GE Healthcare knows that rising titres upstream are a challenge downstream. That’s why the company is putting its more than 50 years’ downstream experience to work helping you to intensify your process and improve the economy, today and in the future.

Fast Trak Services

Whether you're looking to launch a new molecule, enhance existing capacity or bring biosimilars to emerging markets, GE Healthcare's Fast Trak Services take you to market faster.

Helping to Build a Smarter Diagnostic Assay

When you partner with GE Healthcare’s Life Sciences you get access to a wide selection of high performance, customisable components and solutions for immunoassay and molecular diagnostic applications.

Bioprocess Insights Into Next-Generation Manufacturing

The biopharmaceutical industry has a reputation for being averse to change. This is likely because traditional approaches to drug development have withstood the test of time, delivering safe and effective drugs for decades.

GE Healthcare, Akeso Accelerate Therapy Manufacturing in China

Akeso Pharmaceuticals, a biotech company that focuses in the growth and commercialisation of innovative biologics, will open a facility in Guangzhou, China, based on GE Healthcare Life Sciences’ FlexFactory platform, intended for proficient and cost-effective production of recombinant biologics.

GEHC and NIBRT to Enhance Talent Growth in Single-Use Bioprocessing

GE Healthcare (GEHC) and the National Institute of Bioprocessing Research and Training (NIBRT) in Dublin, Ireland are partnering to combine their expertise to deliver educational programming on biopharmaceutical and cell therapy development and manufacturing.

United BioPharma Selects GE Healthcare’s FlexFactory

United BioPharma (UBP) has selected GE Healthcare’s FlexFactory manufacturing platform for its new facility focusing on late-stage clinical and commercial production capacity of therapeutic monoclonal antibodies in Hsinchu Industrial Park, Taiwan.

GE Healthcare Invests in Zenith Technologies

GE has completed a strategic minority investment in Irish-owned Zenith Technologies, a leading technology company delivering manufacturing software systems and solutions for the life sciences industry.

GE Healthcare Bio-Sciences AB - Sweden

Bjorkgatan 30

SE-75184 Uppsala

Sweden

+ 46 771 400 600 + 46 18 612 19 10 www.gelifesciences.com
GE Healthcare Europe GmbH - Germany

Munzinger Strasse 5

D-79111 Freiburg

Germany

+49 0800 9080 711 +49 0800 9080 712 www.gelifesciences.com
GE Healthcare UK Limited - UK

Amersham Place

Little Chalfont

Buckinghamshire

HP7 9NA

United Kingdom

+44 0800 515 313 +44 0800 616 927 www.gelifesciences.com
GE Healthcare Bio-Sciences Corp. - USA

100 Results Way

Marlborough, MA

01752

United States of America

+ 1 800 526 3593 + 1 877 295 8102 www.gelifesciences.com
GE Healthcare Japan Corporation - Japan

Sanken Bldg.3-25-1

Hyakunincho Shinjuku-ku

Tokyo 169-0073

Japan

+ 81 3 5331 9336 + 81 3 5331 9370 www.gelifesciences.com